Aptinyx Announces Recommencement of Phase 2 Study of NYX-2925 in Patients With Painful Diabetic Peripheral Neuropathy - StreetInsider.com

Submitted by Anonymous (not verified) on Mon, 01/04/2021 - 13:06

Aptinyx Announces Recommencement of Phase 2 Study of NYX-2925 in Patients With Painful Diabetic Peripheral Neuropathy  StreetInsider.com